TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT04919980: TVMR With the INNOVALVE System Trial - Early Feasibility Study

Sponsor: Edwards Lifesciences · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 85 pts

Competing Trials Overlap

13 Active Trials

Excess Burn Exposure

$2,357,200

Rescue Site Savings

+$1,560,400

Unlock Full NCT04919980 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04919980 Rescue Dossier →